1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
(
- Contribution to journal › Article
- 2018
-
Mark
Insensitivity to atorvastatin is associated with increased accumulation of intracellular lipid droplets and fatty acid metabolism in breast cancer cells
(
- Contribution to journal › Article
-
Mark
Adipocytes and Obesity-Related Conditions Jointly Promote Breast Cancer Cell Growth and Motility : Associations With CAP1 for Prognosis
(
- Contribution to journal › Article
-
Mark
Statins : a role in breast cancer therapy?
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Global transcriptional changes following statin treatment in breast cancer.
(
- Contribution to journal › Article